Aura Biosciences Inc.

Last updated September 27, 2026

Organization details

Legal name
Aura Biosciences Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Delaware
Headquarters city
Boston
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
AURA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001501796
EIN
32-0271970

Board of directors

Director election results

Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 7 other boards. 7 are in the same sector.

Network of Aura Biosciences Inc.'s board connections Alumis Inc. Alumis Inc. Bicara Therapeutics Inc. Bicara Therapeutics In... Innoviva Inc. Innoviva Inc. LeonaBio Inc. LeonaBio Inc. Mereo BioPharma Group plc Mereo BioPharma Group... Ocular Therapeutix Inc. Ocular Therapeutix Inc... Zentalis Pharmaceuticals Inc. Zentalis Pharmaceutica... Antony C. Mattessich Antony C. Mattessich David Michael Johnson David Michael Johnso... Jeremy Bender Jeremy Bender Natalie C. Holles Natalie C. Holles Sapna Srivastava Sapna Srivastava Aura Biosciences Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$39,921,231
11 sales by 7 insiders
Date Insider Transaction Shares Price Value
Sep 1, 2026 Abu-Absi Susan Officer (Chief Operating Officer) Grant or award +134,513 — —
Sep 1, 2026 Person Julie Officer (Chief People Officer) Grant or award +107,611 — —
Sep 1, 2026 Hopkins Janet Jill Officer (Chief Medical Officer) Grant or award +58,850 — —
Sep 1, 2026 Elazzouzi Amy Officer (SVP, Finance & PAO) Grant or award +23,540 — —
Sep 1, 2026 Kratz Erica Officer (Chief Reg. & Quality Officer) Grant or award +100,885 — —
Jul 7, 2026 Jeremy Bender Director Grant or award +30,000 — —
Jul 1, 2026 Kilroy Conor Officer (See Remarks) Grant or award +14,858 — —
Jun 16, 2026 Anthony S. Gibney Officer (See Remarks) Open-market sale −12,824 $6.42 $82,330
Jun 11, 2026 Teresa Marie Bitetti Director Grant or award +15,000 — —
Jun 11, 2026 Sapna Srivastava Director Grant or award +15,000 — —
Jun 11, 2026 David Michael Johnson Director Grant or award +15,000 — —
Jun 11, 2026 Antony C. Mattessich Director Grant or award +15,000 — —
May 19, 2026 Natalie C. Holles Director, Officer (See Remarks) Grant or award +600,118 — —
May 19, 2026 Natalie C. Holles Director, Officer (See Remarks) Grant or award +553,844 — —
May 7, 2026 Matrix Capital Management Company, LP 10% owner Open-market sale −6,922,870 $5.64 $39,044,987

Organizations in the same sector, closest in location and size first.

Questions about Aura Biosciences Inc.

How many directors are on Aura Biosciences Inc.'s board?

Aura Biosciences Inc.'s board has 8 directors: Antony C. Mattessich, David Michael Johnson, Jeremy Bender, Los Pinos Elisabet De, Natalie C. Holles, Rajesh B. Parekh, Sapna Srivastava and Teresa Marie Bitetti.

Are Aura Biosciences Inc. insiders buying or selling shares?

Over the last 12 months, Aura Biosciences Inc. insiders made no open-market purchases and sold $39.9 million of shares in 11 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="aura-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.